The US Isn't Using Full Potential When it Comes to Medicine

Additional Details
Published Date:
Video Transcript

Interviewer: You touched on HGH, a growth hormone, a little bit. That's been pretty controversial. Why is that and why is it potentially beneficial?

Dr. Kugler: Yeah, well, yo have to look back at orthodox medicine as many of us see it, they don't really look fro cures. They want to keep us sick and in pain, that's the medical system, right? Numbers actually clearly support our thinking. Every year there's a number of groups that release the standing or the ranking of different countries in the world. Guess what? Previously the U.S. was something like between 40 and 60. Well, this year 37, 47 and 52. Now, with our capacity we could be number one in the world. Now, emergency medicine is fantastic, we have the equipment. Analytical tools, it's absolutely magnificent but the application down the road is not really what we think should be done. I mean if you have a disease, the number one effort should be to find a cure for that disease, not just cover it up with some drugs. And that's totally, it's definitely happening here. We see there's some underdeveloped countries that are lucky enough to have a climate where they can grow crops, raise some animals, and on the other hand, don't have enough money to buy our drugs. And guess what? They're right up there with the top people in the world. It's really, it's almost a joke. Take this a little bit forward, we totally believe that stem cells, the real stem cells, the ones with full telomere lengths, with your DNA, like the embryonic-equivalent stem cells. But this is never going to happen int he U.S.? Because if they do, and streamline that approach, its now estimated - because we already know the different steps from A to Z - how to get there. As a matter of fact, to everybody's surprise, Oregon University made human stem cells via the nuclear transfer approach. And I talked to them, and it was really kind of at first really polite. And then it was like, "Well, we just wanted to do it so we just did it." And it worked. The other approach to make stem cells fully active, not really fully active because I haven't done it yet is the IPS approach; induced prorepotent stem cells. What you have to do there is, you have to take four retroviruses. A retrovirus inserts itself into your own DNA and four different retroviruses with four different control genes, You're supposed to put that into your skin cells and then the skin cell behaves like a stem cell? No, it doesn't work this way. I'm a laboratory guy and I know what I can do in a laboratory. And this is one of the reasons I wrote my book, "The Lifelong Health: Learn How to Control Your Genes to Stay Young With Age" and if you want to know a little bit more about that, go to our website and you'll see our laboratory, our equipment, our hypothesis, what we're dong from the basis up and so on and so on. So, if we streamline making specific stem cells via nuclear transfer, it's estimated it wold cost a mere $18,000 per person. And then you'd be totally regenerated and you wouldn't need any drugs and so on. Naturally, they're not going to let this happen. That's why many researchers go to different countries. I was in Japan, I was in Mexico City, I was in Thailand. you know, sort of, I was sending out my feelers, possibly what could possible be done in the future.
Dr. Hans Kugler explains why the United States continues to rank lower vs its potential in terms over overall health care. He discusses the current medical system and how the US could improve by eliminating restrictions on such things as hormones and stem cell treatments.

RATE THIS VIDEO: powered by mojirater

In order to keep our content free, some of the links may be affiliate links to trusted websites. Shopping through them will bring a small commission to Read our full affiliate disclaimer for more info.